Inve US ▾
ELELV

Elevance Health (ELV) Q1 FY26 earnings call

Earnings call· Mar 2026 (Q1 FY26)· Health Care· Apr 22, 2026

Source: earnings call transcript

Elevance opened FY26 with a clean operating beat management credits to disciplined execution rather than a friendlier trend backdrop, giving it confidence to lift the full-year outlook and reaffirm a return to double-digit earnings growth in 2027. The quarter's core tension is a stabilizing commercial and Medicare franchise plus scaling Carelon and AI cost levers, set against still-underwater Medicaid margins and an unresolved CMS risk-adjustment overhang management insists does not affect the operating outlook.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

ELV operating KPIs by quarter

ELV operating KPIs stated on its earnings calls, by fiscal quarter
KPI Mar 2025 Q1 FY25 Jun 2025 Q2 FY25 Sep 2025 Q3 FY25 Dec 2025 Q4 FY25This call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26 Sep 2026 Q3 FY26Change vs prior quarter
Medical members
45.8M We ended the first quarter with 45.8 million medical members, up 99,000 from year-end, driven primarily by targeted expansion and better-than-expected retention rates in Medicare Advantage. Source: earnings call transcript
45.6M We ended the second quarter with 45.6 million medical members, down approximately 200,000 sequentially, driven by a reduction in Medicaid membership and lower effectuation rates in our ACA business, a dynamic we first highlighted on last quarter's earnings call. Source: earnings call transcript
45.4M We ended the quarter with 45.4 million medical members. Source: earnings call transcript
45.2M We ended the year with 45.2 million members, a decrease of approximately 500,000 year-over-year, principally reflecting a decline in Medicaid membership due to continued eligibility reverifications. Source: earnings call transcript
45.4M We ended March with 45.4 million members, an increase of nearly 200,000 from year-end, driven by growth in our commercial fee-based membership and higher enrollment in Individual ACA. Source: earnings call transcript
44.9M We ended the quarter with 44.9 million medical members. Source: earnings call transcript
~44.9M We ended the quarter with approximately 44.9 million medical members. Source: earnings call transcript
—
Medical care ratio
86.4% Our consolidated benefit expense ratio was 86.4%, an increase of 80 basis points year-over-year. Source: earnings call transcript
88.9% The consolidated benefit expense ratio was 88.9%, an increase of 260 basis points year-over-year, driven by our ACA and Medicaid businesses, partially offset by a favorable out-of-period settlement with a value-based care provider. Source: earnings call transcript
91.3% The consolidated benefit expense ratio was 91.3%, aligned with our expectations. Source: earnings call transcript
93.5% Our consolidated benefit expense ratio was 93.5% for the quarter and 90% for the full year, in line with our guidance. Source: earnings call transcript
86.8% Our consolidated benefit expense ratio was 86.8%. Source: earnings call transcript
—
90.6% Our consolidated benefit expense ratio was 90.6%, an improvement of 70 basis points. Source: earnings call transcript
—
Days in claims payable ———
41.3 Days in claims payable was 41.3 days, a decrease of 0.1 days sequentially. Source: earnings call transcript
46.6 Days in claims payable were 46.6 days, an increase of 5.3 days sequentially. Source: earnings call transcript
45.4 Days in claims payable were 45.4 days as of June 30, an increase of 2.9 days year-over-year. Source: earnings call transcript
44.9 Days in Claims Payable were 44.9 days as of September 30, an increase of 3.5 days year-over-year. Source: earnings call transcript
-1.1%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.